Industries › Healthcare › In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances
Market cap, price, and daily change for the 18 In Vitro & In Vivo Diagnostic Substances stocks we cover.
1–18 of 18
| IDXX | Idexx Laboratories | 561.89 | +2.91% | $44.3B |
| LNTH | Lantheus Holdings, Inc. | 103.91 | +0.67% | $6.8B |
| CLDX | Celldex Therapeutics, Inc. | 32.42 | -1.47% | $2.5B |
| NTLA | Intellia Therapeutics, Inc. | 15.65 | +2.25% | $2.2B |
| NEOG | Neogen Corp | 9.30 | +4.14% | $2.0B |
| QDEL | Quidelortho Corp | 13.67 | +4.27% | $932M |
| ACHV | Achieve Life Sciences, Inc. | 4.83 | -9.72% | $496M |
| MYGN | Myriad Genetics Inc | 4.54 | +3.65% | $429M |
| TKNO | Alpha Teknova, Inc. | 5.25 | +6.38% | $282M |
| IMDX | Insight Molecular Diagnostics Inc. | 5.46 | +2.25% | $176M |
| ICCC | IMMUCELL CORP /DE/ | 9.46 | +0.53% | $86M |
| QCLS | Q/C TECHNOLOGIES, INC. | 4.02 | +4.28% | $32M |
| VNRX | VOLITIONRX LTD | 1.47 | +6.14% | $12M |
| CDIO | Cardio Diagnostics Holdings, Inc. | 2.03 | +2.53% | $6M |
| BMRA | BIOMERICA INC | 1.88 | -4.34% | $6M |
| VRAX | Virax Biolabs Group Ltd | 0.18 | +6.81% | — |
| NNNN | Anbio Biotechnology | 16.60 | +3.11% | — |
| TRIB | TRINITY BIOTECH PLC | 0.59 | +2.24% | — |
Industry classification from SEC EDGAR (SIC) · Databento EQUS.MINI (prices). Informational only — not financial advice.